Please assess the completion status of the following clinical trial:

Trial Title: Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. They have three-months of persistent symptoms meeting criteria for chronic rhinosinusitis as defined by the Taskforce on Rhinosinusitis.~2. They have a CT-scan in our clinic or have a viewable recent (\< 3weeks prior to clinic visit) CT-scan with a Lund Mckay score of 6 or greater. A Lund Mckay score of 6 or greater is felt to be indicative of at least moderate CRS.~3. They do not have nasal polyps on initial clinic nasal endoscopy~4. They are willing to participate in a clinical study~5. They are between the ages of 18 to 80.~Exclusion Criteria:~1. They have a condition in which the use of systemic corticosteroids is contraindicated such as diabetes will be excluded.~2. They are unable to or unwilling to take the prescribed antibiotics or steroids will excluded.~3. They have been treated with a \> 3 week course of antibiotics and/or systemic steroids will also be excluded.~4. They have variants of chronic sinusitis known to be refractory to medical therapy such as Wegener's granulomatosis, primary ciliary dyskinesia or sarcoidosis.~5. They have sinusitis secondary to prior surgery, a dental procedure or anatomical variants.~6. They have nasal polyps on physical exam.~7. They are pregnant. Subjects who are possibly pregnant will be excluded based on history. Pregnancy testing is not standard of care for diagnostic imaging.~8. They have a Lund-Mckay score on CT scan of \< 6~9. They are \< 18 or \> 80 years old

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Prednisone (Type: ACTIVE_COMPARATOR): Oral steroid medication
- Topical Mometasone (Type: ACTIVE_COMPARATOR): Topical steroid medication

Based on this trial design, predict the completion outcome and termination type (if applicable).